Carotid Endarterectomy Should Not Be Recommended to End-Stage Kidney Disease Patients with Asymptomatic Carotid Artery Disease.

Hafeez, Muhammad Saad; Abdul-Malak, Othman M; Eslami, Mohammad H; Chaer, Rabih A; Yuo, Theodore H

Hafeez, Muhammad Saad; Abdul-Malak, Othman M; Eslami, Mohammad H; Chaer, Rabih A; Yuo, Theodore H.

Affiliation

Hafeez MS; Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: saad.hafeez@alumni.aku.edu.
Abdul-Malak OM; Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Eslami MH; Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Chaer RA; Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Yuo TH; Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: yuoth@upmc.edu.

Ann Vasc Surg ; 101: 53-61, 2024 Apr.

Article in En | MEDLINE | ID: mdl-37914071

Subject(s)

Carotid Artery Diseases; Carotid Stenosis; Endarterectomy, Carotid; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Stroke; Humans; Aged; United States/epidemiology; Middle Aged; Endarterectomy, Carotid/adverse effects; Carotid Stenosis/complications; Carotid Stenosis/diagnostic imaging; Carotid Stenosis/surgery; Risk Assessment; Treatment Outcome; Medicare; Kidney Failure, Chronic/diagnosis; Kidney Failure, Chronic/therapy; Kidney Failure, Chronic/complications; Risk Factors; Stroke/etiology; Heart Failure/etiology; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carotid Artery Diseases / Endarterectomy, Carotid / Carotid Stenosis / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Stroke / Heart Failure / Kidney Failure, Chronic Limits: Aged / Humans / Middle aged Country/Region as subject: America do norte Language: En Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google